Correlation Between Freeline Therapeutics and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Freeline Therapeutics Holdings and Pulmatrix, you can compare the effects of market volatilities on Freeline Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Pulmatrix.

Diversification Opportunities for Freeline Therapeutics and Pulmatrix

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Freeline and Pulmatrix is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Pulmatrix go up and down completely randomly.

Pair Corralation between Freeline Therapeutics and Pulmatrix

If you would invest  212.00  in Pulmatrix on September 18, 2024 and sell it today you would earn a total of  363.00  from holding Pulmatrix or generate 171.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Freeline Therapeutics Holdings  vs.  Pulmatrix

 Performance 
       Timeline  
Freeline Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Pulmatrix 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Freeline Therapeutics and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Freeline Therapeutics and Pulmatrix

The main advantage of trading using opposite Freeline Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Freeline Therapeutics Holdings and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data